1. Home
  2. VSTM vs GRAF Comparison

VSTM vs GRAF Comparison

Compare VSTM & GRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
    SELLHOLDBUYas of 18 hours ago
  • GRAF
    SELLHOLDBUYas of 2024 years ago
  • Stock Information
  • Founded
  • VSTM 2010
  • GRAF 2021
  • Country
  • VSTM United States
  • GRAF United States
  • Employees
  • VSTM N/A
  • GRAF N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • GRAF
  • Sector
  • VSTM Health Care
  • GRAF
  • Exchange
  • VSTM Nasdaq
  • GRAF NYSE
  • Market Cap
  • VSTM 313.1M
  • GRAF 292.7M
  • IPO Year
  • VSTM 2012
  • GRAF 2024
  • Fundamental
  • Price
  • VSTM $6.08
  • GRAF $10.25
  • Analyst Decision
  • VSTM Strong Buy
  • GRAF
  • Analyst Count
  • VSTM 8
  • GRAF 0
  • Target Price
  • VSTM $13.00
  • GRAF N/A
  • AVG Volume (30 Days)
  • VSTM 988.6K
  • GRAF 3.5K
  • Earning Date
  • VSTM 03-20-2025
  • GRAF 01-01-0001
  • Dividend Yield
  • VSTM N/A
  • GRAF N/A
  • EPS Growth
  • VSTM N/A
  • GRAF N/A
  • EPS
  • VSTM N/A
  • GRAF 0.30
  • Revenue
  • VSTM $10,000,000.00
  • GRAF N/A
  • Revenue This Year
  • VSTM N/A
  • GRAF N/A
  • Revenue Next Year
  • VSTM $867.23
  • GRAF N/A
  • P/E Ratio
  • VSTM N/A
  • GRAF $33.62
  • Revenue Growth
  • VSTM N/A
  • GRAF N/A
  • 52 Week Low
  • VSTM $2.10
  • GRAF $9.03
  • 52 Week High
  • VSTM $13.52
  • GRAF $11.02
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 42.16
  • GRAF N/A
  • Support Level
  • VSTM $6.01
  • GRAF N/A
  • Resistance Level
  • VSTM $6.89
  • GRAF N/A
  • Average True Range (ATR)
  • VSTM 0.47
  • GRAF 0.00
  • MACD
  • VSTM -0.14
  • GRAF 0.00
  • Stochastic Oscillator
  • VSTM 11.83
  • GRAF 0.00

Stock Price Comparison Chart: VSTM vs GRAF

VSTM
GRAF
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025051015202530354045505560VSTM VS GRAF

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About GRAF GRAF GLOBAL CORP

Graf Global Corp is a blank check company.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use